No Additional AE; a patient received their initial dose of ROTATEQ at 5 months old.; This spontaneous report was received from an Other Health Professional and refers to a 5-month-old male patient. The patient’s medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not reported. On an unknown date in 2024, at the age of 5 months old, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid (2 ml, lot #y003754 has been verified to be a valid lot number, expiration date not reported but upon internal validation established as 25-OCT-2025) orally for prophylaxis (strength was not provided) (inappropriate schedule of product administration). No additional doses have been given at this time. No additional adverse event (no adverse event) was reported.